Celance and pulmonary fibrosis Patient Reports February 11, 2012

Celance Side Effects Report #5273409-4
Celance side effect was reported by a Consumer or non-health professional from FRANCE on Mar 09, 2007. Male patient, 83 years of age, was diagnosed with parkinson's disease  and was treated with Celance. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, hyponatraemia, interstitial lung disease, pulmonary fibrosis , pulmonary hypertension , right ventricular failure, subileus. Celance dosage: 2 MG; QD; PO. During the same period patient was treated with CARBIDOPA, ENTACAPONE, LEVODOPA, PLAVIX, IKOREL. Patient was hospitalized. Patient died on 02/20/2007.